New drug approved to treat HIV-1 - KCBD NewsChannel 11 Lubbock

New drug approved to treat HIV-1

Updated:
  • HealthMore>>

  • The 'Hobby Lobby ruling' and what it means for U.S. health care

    The 'Hobby Lobby ruling' and what it means for U.S. health care

    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
  • Diet changes can alter gut bacteria

    Diet changes can alter gut bacteria

    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
  • Lift U.S. ban on blood donations by gay men

    Lift U.S. ban on blood donations by gay men

    The United States should repeal a 30-year policy that bans blood donations from gay and bisexual men, according to a team of medical and legal experts writing this week in the Journal of the American Medical...
    The United States should repeal a 30-year policy that bans blood donations from gay and bisexual men, according to a team of medical and legal experts writing this week in the Journal of the American Medical Association.

TUESDAY, Aug. 13 (HealthDay News) -- Tivicay (dolutegravir) has been approved by the U.S. Food and Drug Administration to treat infection with HIV-1, a strain of the virus that causes AIDS.

The drug, among a class called integrase strand transfer inhibitors, interferes with an enzyme that HIV needs to multiply. It's been approved in combination with other antiretroviral drugs and for people aged 12 and older who weigh at least 40 kilograms (approximately 88 pounds), the FDA said in a news release.

Some 50,000 Americans acquire HIV infection each year, and about 15,500 people died from the disease in 2010, the agency said, citing the U.S. Centers for Disease Control and Prevention.

The drug's safety and effectiveness were evaluated in clinical studies involving more than 2,500 adults and children, the FDA said. The most common side effects included difficulty sleeping, headache and more serious problems including allergic-like reactions and abnormal liver function in people who had hepatitis B or C.

Tivicay is produced by GlaxoSmithKline, based in Research Triangle Park, N.C.

More information

The U.S. Department of Health and Human Services's AIDS.gov website has more about HIV/AIDS.

Copyright © 2013 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.